Apatinib and Etoposide capsule

DRUG2 trials

Sponsors

Henan Cancer Hospital, Jiangsu HengRui Medicine Co., Ltd.

Conditions

Ovarian CancerSmall Cell Lung Cancer

Phase 2

Study of Apatinib Plus Etoposide Capsule as the Therapy of Advanced Small Cell Lung Cancer

Henan Cancer HospitalSmall Cell Lung Cancer

Start: 2017-11-29End: 2021-11-01Target: 60Updated: 2020-07-10

Apatinib and Etoposide Capsule Versus Apatinib in Patients With Platinum Resistant Ovarian Cancer

Jiangsu HengRui Medicine Co., Ltd.Ovarian Cancer

Start: 2020-05-31End: 2021-06-30Target: 54Updated: 2020-05-12

Related Papers

Efficacy, safety and pharmacokinetics of apatinib plus etoposide versus apatinib alone for platinum-resistant recurrent ovarian cancer: protocol of a multicenter, open-label, randomized phase 2 trial

Translational Cancer Research2023-10-012 citations